AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02279316 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Vi-De 3
Description: All participants receive a dose of 800 IU vitamin D3 per day as a standard of care. 800 IU Vitamin D is the dose that is currently recommended by the Swiss Health Department (Bundesamt für Gesundheit) for seniors over 60.
Study NCT02279316 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Jaques-Dalcroze eurhythmics
Description: The Jaques-Dalcroze eurhythmics method includes different courses of motion (multi-task exercises) that are conducted to the rhythm of improvised piano music. A session starts with a short warm-up that includes simple exercises to get body and mind prepared for the rest of the exercise session. The complexity of the exercises increases gradually during the session: starting with single tasks and then combining them into a multi-task exercise gradually increasing complexity.
Study NCT02279316 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home exercise program
Description: The home exercise program is a strengthening program that will consist of five simple exercises.
Study NCT04491279 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Home 'General' exercise instructions.
Description: Participants will be given a home exercise programme weekly based on exercises from the general exercise class and will be asked to complete these independently at home twice more during the week and to keep a training diary.
Study NCT04491279 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Home 'Neuropilates' exercise instructions.
Description: Participants will be given a home exercise programme weekly based on exercises from the neuropilates exercise class and will be asked to complete these independently at home twice more during the week and to keep a training diary.
Study NCT04491279 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Supervised Neuropilates Group Class
Description: Will attend a once-weekly 60-minute neuropilates exercise class over 6 weeks facilitated by the principle investigator (a chartered physiotherapist who is also a pilates instructor).
Study NCT04491279 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Supervised General Exercises Group Class
Description: Will attend a once weekly, 60-minute generalized exercise class which will be designed by a chartered physiotherapist to address strength, cardiorespiratory fitness and mobility
Study NCT03013595 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TRAM feedback
Study NCT02677584 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prophylactic caffeine citrate
Description: Prophylactic caffeine (group1) will be defined as caffeine prescribed for preterm infant within the first 72 hours of life prior to manifest apnea . patients will be randomly assigned to receive caffeine in loading dose 20 mg/kg (equivalent for 10 mg/kg caffeine base) and maintenance dose 10 mg/kg/day (equivalent for 5 mg/kg caffeine base) .
Study NCT02677584 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic caffeine citrate
Description: Therapeutic caffeine ( group 2 ) will be defined as caffeine prescribed for manifest apnea within or after the first 72 hours of life . patients will be randomly assigned to receive caffeine in loading dose 20 mg/kg (equivalent for 10 mg/kg caffeine base) and maintenance dose 10 mg/kg/day (equivalent for 5 mg/kg caffeine base).
Study NCT03443024 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Description: Sterile liquid solution administered subcutaneously.
Study NCT03443024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Solution administered subcutaneously.
Study NCT01870570 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food Product E: Breakfast Biscuit
Study NCT01870570 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food Product F: White Bread
Study NCT03443024 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Solution administered subcutaneously.
Study NCT02509338 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrode deep brain stimulation (Monopolar DBS Lead Model 09064-40cm)
Description: Deep brain stimulation surgery with implantation of one contact-electrode deep brain stimulation electrodes bilaterally in the internal globus pallidum for treating dystonia
Study NCT03964662 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WeReha
Description: Rehabilitation of stroke patients with the device WeReha
Study NCT00693459 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Circular Anal Dilator for Transanal Hemorrhoidectomy
Description: The Circular Anal Dilator for Transanal Hemorrhoidectomy (product #CAD01) allows the standard of care Ferguson hemorrhoidectomy to be performed and does not alter the steps of the operation. The presumed advantages are the ability of the dilator to guide an accurate dissection and also to decrease the overall time it takes to perform hemorrhoidectomy.
Study NCT02346370 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PEGylated recombinant human hyaluronidase PH20
Study NCT02346370 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Study NCT01911325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buparlisib
Study NCT01911325 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Buparlisib matching placebo
Study NCT04487158 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Small Changes
Description: The Small Changes program is an evidence-based 6-month weight-management program. The program runs weekly for 3 months followed by by-weekly contact for 3-months (1x in-person group and 1x phone call). This program uses behaviour change strategies to help with weight loss. The Small Changes approach is different from traditional dieting programs because it encourages modest changes to diet and physical activity which are not overly taxing to maintain. Participants are asked to reduce their nutritional intake by 200-400 calories per day. You will also be asked to increase their daily step count by 2000-3000 steps. Weekly intervention topics include: Monitoring, Nutrition, Physical Activity, Breaking the Chain, External Cues, Mindful Eating, Body Image, Stress, Sleep, Social Support, Social Eating, and the Stoplight Guide.
Study NCT01911325 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Study NCT01911325 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Docetaxel
Study NCT02287025 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regorafenib (Stivarga, BAY73-4506)
Description: Dose(s) 160 mg tablet (4 tablets per day at 40 mg) daily for 3 weeks on / 1 week off
Study NCT02287025 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Regorafenib (Stivarga, BAY73-4506)
Description: Dose(s) 160 mg tablet (4 tablets per day at 40 mg) daily for 3 weeks on / 1 week off
Study NCT02287025 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: iPAD application
Description: Investigators were supported with enhanced drug-specific information via an iPad application (SMART).
Study NCT02287025 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bayer specialist
Description: The treating investigator will have access to the prescribing information and have ability to consult a Bayer specialist, should questions arise.
Study NCT03368430 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: After performing scaling and root planing (SRP) in the test group, melatonin 10 mg oral capsule was taken once daily at night prior to bedtime for only 2 months during the 6-month study period
Study NCT03368430 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: After finishing scaling and root planing (SRP) in the control group, placebo capsule was taken once daily at bedtime for two months.
Study NCT04487158 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: INSPIRE
Description: The INSPIRE program is a modification to the Small Changes program. It combines elements of positive psychology and behaviour change to help with weight loss. The first four weeks of the program are oriented towards improving well-being and include topics such as values, self-compassion/mindfulness, character strengths, and gratitude. The remaining 8 weeks mirrors the Small Changes program in making modest changes to diet and physical activity to achieve weight loss. Participants are asked to reduce their nutritional intake by 200-400 calories per day. Participants will also be asked to increase their daily step count by 2000-3000 steps.
Study NCT03298880 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Supine VM VAD
Description: Valsalva strain delivered using VAD
Study NCT00782249 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation paradigm #1
Description: Vagus nerve stimulation parameters #1
Study NCT00782249 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation paradigm #2
Description: Vagus nerve stimulation parameters #2
Study NCT00782249 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation paradigm #3
Description: Vagus nerve stimulation parameters #3
Study NCT04184908 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gel xerostomia
Description: Apply 2-3 cm of the gel on the tongue, gums and oral mucosa, at least three times a day, if necessary it can be applied at night
Study NCT04184908 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: gel placebo
Description: Apply 2-3 cm of the gel on the tongue, gums and oral mucosa, at least three times a day, if necessary it can be applied at night
Study NCT03298880 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Supine VAD manometer
Description: supine Valsalva strain delivered using manometer
Study NCT03298880 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Modified VM VAD
Description: modified VM using VAD
Study NCT03298880 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Modified VM Manonmeter
Description: Postural modified position VM using manometer
Study NCT03804749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: suramin sodium
Description: The trial will start from the low dose (10mg/kg) group, followed by the middle dose (15mg/kg) and high dose (20mg/kg) groups, only after the safety in the previous dose group has been demonstrated.。
Study NCT03804749 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo is 0.9% sodium chloride injection.
Study NCT04196907 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rad-67 Pulse CO-Oximeter and DCI Mini sensor
Description: Noninvasive Pulse CO-Oximeter device and sensor are used to measure hemoglobin.
Study NCT00829764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxycycline Monohydrate
Description: 25 mg 5 mL dose
Study NCT00829764 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxycycline Monohydrate
Description: 25 mg 5 mL dose
Study NCT04336228 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Escitalopram
Description: 20mg daily for 3-4 weeks.
Study NCT04336228 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: 20mg placebo tablet daily for 3-4 weeks.
Study NCT02328469 — intervention group
Intervention type: DRUG
Intervention: Ceftriaxone or Doxycycline
Description: beside symptomatic therapy (metamizole, paracetamol, thiethylperazine, saline), patients with proven or probable Lyme neuroborreliosis will be treated with ceftriaxone 2 g intravenously once daily for 14 days OR doxycycline 100 mg orally twice daily for 14 days
Study NCT02328469 — intervention group
Intervention type: OTHER
Intervention: questionnaire
Description: Control subjects will be asked to answer a questionnaire asking about the presence and frequency of nonspecific symptoms.
Study NCT02328469 — intervention group
Intervention type: DRUG
Intervention: Acyclovir
Description: Patients will be treated with intravenous acyclovir 10 mg per kg three times daily for 14 to 21 days.
Study NCT00689988 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: speech-language therapy with AAC intervention
Description: speech-language intervention in weekly 40-minutes sessions, without the presence of parents or caregivers, and 5 to 10-minutes to parents training and orientation
Study NCT02757495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Single dose caudal epidural injection will be done using 25 G needle. patients of Group BD will be given dexmedetomidine (precedex 100 µg/mL parenteral preparation (Hospira ® ) 2 µg/kg in 1 ml/kg bupivacaine 0.25%,
Study NCT01186432 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PDS 1.0
Study NCT00499265 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: gemcitabine hydrochloride
Description: 1000 mg/m2 as 30 min i.v. infusion once weekly for 7/8 weeks and then every 3/4 weeks
Study NCT00499265 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Serine Proteinase Inhibitor WX-671
Description: oral, daily
Study NCT02449330 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teneligliptin
Study NCT00002850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ciprofloxacin
Description: Begin oral ciprofloxacin when they start chemotherapy for multiple myeloma. Assigned treatment consists of ciprofloxacin (Cipro 500 mg po tablet every 12 hours for two months. The patient will continue to be observed one additional month on study continuing regular myeloma chemotherapy.
Study NCT00002850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ofloxacin
Description: Begin oral ofloxacin when they start chemotherapy for multiple myeloma. Assigned treatment consists of ofloxacin (500 mg po tablet every 12 hours for two months. The patient will continue to be observed one additional month on study continuing regular myeloma chemotherapy.
Study NCT00002850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 160 mg trimethoprim and 800 mg sulfamethoxazole
Description: Begin oral TMP-SMX when they start chemotherapy for multiple myeloma. Assigned treatment consists of TMP-SMX (Septra® or Bactrim®) 1 DS tablet \[TMP-SMX DS = 160 mg trimethoprim and 800 mg sulfamethoxazole\] every 12 hours for two months..
Study NCT01939795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise training and/or CRT
Description: Three 40-minute exercise sessions per week on a treadmill for four months
Study NCT02001740 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triamcinalone (steroid) and lidocaine
Description: receive once
Study NCT02001740 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Lidocaine
Description: receive once
Study NCT02680067 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine Green
Description: A trained physician will inject 0.1 ml of Indocyanine Green into the web spaces of the hands in both upper extremities. Subjects may have up to five study visits to confirm feasibility, safety, and reproducibility.
Study NCT03683901 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS
Description: Electrical Stimulation
Study NCT03683901 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: t-NMES
Description: Electrical Stimulation
Study NCT03683901 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No stimulation
Description: No stimulation
Study NCT04787458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: abdomen binder (Sejung Korea, Seoul, Republic of Korea)
Description: abdomen binder with a standard height of 22 cm (Sejung Korea, Seoul, Republic of Korea)
Study NCT01293877 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Laparoscopy surgery for morbid obesity
Description: The intervention will compare the 2 restrictive procedures one sleeve gastrectomy and gastric plication/
Study NCT02746939 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: InSciEd Out Fitness and Nutrition Curriculum
Description: Science curriculum is designed in partnership with 3rd and 4th grade teachers and InSciEd Out scientists. The curriculum is designed to focus on inquiry driven science, and also aims to decrease high risk behaviors that can lead to obesity in the students.
Study NCT04234230 — intervention group
Intervention type: OTHER
Intervention: Prevalence Survey
Description: Questionnaire survey on self-management
Study NCT00855478 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cypher stent ™ or Cypher Select ™
Description: Cypher drug-eluting stent
Study NCT01995357 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Coloplast Test A
Description: Coloplast Test A is a newly developed ostomy appliance
Study NCT02908321 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT
Description: The group based manualised CBT intervention consists of The Cool Kids Anxiety Program: Autism Spectrum Disorder Adaptation (Cool Kids ASD).
Study NCT02890186 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Narcotrend
Description: the investigator modified the effect-site target concentrations by NI.If NI fall down to 46 and keep 46 more than 30 seconds,propofol and remifentanil were infused as feedback automatically to achieve the target NI of 26-46.
Study NCT02680067 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MultiSpectral Imaging System
Description: Once the Indocyanine Green is injected, the contrast is expected to fluoresce underneath the MultiSpectral Imaging System. Multispectral video and still images will be recorded at the study visits.
Study NCT03968146 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector Spinae Plane Block
Description: The linear multi-frequency 6-13 megahertz transducer will be used. In the prone position,under aseptic conditions, the probe will be placed in a longitudinal position 2-3 cm lateral to the vertebral column. The transverse processes of the vertebrae at (mid) level of surgery, the Erector Spinae muscle and the psoas muscle are identified. A 22 gauge echogenic needle will be inserted in an in plane technique in a cephalad to caudad direction until bone contact with the top of the transverse process is reached. After slight retraction of the needle, A test dose of 5% dextrose in water can expand the fascial plane and confirm needle-tip location prior to injection of local anaesthetic. Then, 0.5 ml/kg of bupivacaine 0.25% with 0.1 mg/kg dexamethasone and adrenaline 1 : 200000 will be injected between erector spinea muscle and transverse process, taking in consideration not exceeding the toxic dose of bupivacaine; 4 mg/kg . the same procedure will be repeated on the contralateral side.
Study NCT03968146 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Fentanyl
Description: patients will receive an induction dose at 1 mcg/kg. If the analgesia was inadequate in the form of increase in heart rate and or arterial blood pressure by more than 20% of baseline values during surgery, this warrants the administration of intravenous fentanyl (0.5µg/kg).
Study NCT03968146 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: patients will receive an induction dose at 1 mcg/kg. If the analgesia was inadequate in the form of increase in heart rate and or arterial blood pressure by more than 20% of baseline values during surgery, this warrants the administration of intravenous fentanyl (0.5µg/kg).
Study NCT02890186 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: experience
Description: the investigator modified the effect-site target concentrations of both drugs without minimum or maximum concentration limits without using the Narcotrend monitor only depend on the experience of anesthesiologist.
Study NCT05468476 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT00834535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefdinir Capsules 300 mg
Description: 1 x 300 mg, single-dose non-fasting
Study NCT00834535 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: OMNICEF® Capsule 300 mg
Description: 1 x 300 mg, single-dose non-fasting
Study NCT02359825 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol (PEG)
Description: For the control groups, epineural repair or interposition grafting will be undertaken in the standard end-to-end fashion using interrupted nylon suture after irrigation of the wound with normal saline as deemed necessary by the operating surgeon. For the experimental group, the nerve(s) will be repaired using standard suture neurorrhaphy techniques and a 149.25 mM (50%) solution of PEG 3.35 kD in sterile water will then be irrigated onto the neurorrhaphy site for one minute. Following this, the approximated nerve ends will be irrigated with sterile water gently for 2 minutes. All wounds will be closed in the fashion deemed appropriate by the operating surgeon.
Study NCT04250545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sapanisertib
Description: Given PO
Study NCT04250545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telaglenastat Hydrochloride
Description: Given PO
Study NCT01995357 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Coloplast Test B
Description: Coloplast Test B is a newly developed ostomy appliance.
Study NCT01995357 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard product
Description: Standard product is the subjects usual product. Only subjects that usually use the CE-marked commercially available SenSura 1-piece flat and SenSura Mio 1-piece are included in the investigation.
Study NCT01155388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferumoxytol
Description: Experimental: Ferumoxytol